Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC.
Dercle L, Fronheiser M, Rizvi NA, Hellmann MD, Maier S, Hayes W, Yang H, Guo P, Fojo T, Schwartz LH, Zhao B, Leung DK. Dercle L, et al. Among authors: fojo t. J Thorac Oncol. 2023 May;18(5):587-598. doi: 10.1016/j.jtho.2022.12.019. Epub 2023 Jan 13. J Thorac Oncol. 2023. PMID: 36646209 Free article. Clinical Trial.
Sotorasib in KRAS-Mutated Colorectal Cancer.
Fojo T. Fojo T. N Engl J Med. 2024 Jul 11;391(2):186-187. doi: 10.1056/NEJMc2406109. N Engl J Med. 2024. PMID: 38986067 No abstract available.
Mitotane and the myth of 14 mg/L.
Ehrlich MI, Labadie BW, Bates SE, Fojo T. Ehrlich MI, et al. Among authors: fojo t. Lancet Oncol. 2024 Jan;25(1):12-15. doi: 10.1016/S1470-2045(23)00537-5. Lancet Oncol. 2024. PMID: 38181804 No abstract available.
Lessons from withdrawn accelerated approvals in oncology.
Mellgard GS, Fojo T, Bates SE. Mellgard GS, et al. Among authors: fojo t. Nat Cancer. 2024 Feb;5(2):211-215. doi: 10.1038/s43018-023-00696-8. Nat Cancer. 2024. PMID: 38291305 No abstract available.
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
Taïeb D, Nölting S, Perrier ND, Fassnacht M, Carrasquillo JA, Grossman AB, Clifton-Bligh R, Wanna GB, Schwam ZG, Amar L, Bourdeau I, Casey RT, Crona J, Deal CL, Del Rivero J, Duh QY, Eisenhofer G, Fojo T, Ghayee HK, Gimenez-Roqueplo AP, Gill AJ, Hicks R, Imperiale A, Jha A, Kerstens MN, de Krijger RR, Lacroix A, Lazurova I, Lin FI, Lussey-Lepoutre C, Maher ER, Mete O, Naruse M, Nilubol N, Robledo M, Sebag F, Shah NS, Tanabe A, Thompson GB, Timmers HJLM, Widimsky J, Young WJ Jr, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Among authors: fojo t. Nat Rev Endocrinol. 2024 Mar;20(3):168-184. doi: 10.1038/s41574-023-00926-0. Epub 2023 Dec 14. Nat Rev Endocrinol. 2024. PMID: 38097671 Review.
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.
Leuva H, Zhou M, Jamaleddine N, Meseha M, Faiena I, Anna Park YH, McWilliams G, Luhrs C, Maxwell KN, Von Hoff D, Bates SE, Fojo T. Leuva H, et al. Among authors: fojo t. EBioMedicine. 2024 Sep;107:105288. doi: 10.1016/j.ebiom.2024.105288. Epub 2024 Aug 23. EBioMedicine. 2024. PMID: 39180789 Free PMC article.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Yeh C, Zhou M, Sigel K, Jameson G, White R, Safyan R, Saenger Y, Hecht E, Chabot J, Schreibman S, Juzyna B, Ychou M, Conroy T, Fojo T, Manji GA, Von Hoff D, Bates SE. Yeh C, et al. Among authors: fojo t. Oncologist. 2023 Feb 8;28(2):139-148. doi: 10.1093/oncolo/oyac217. Oncologist. 2023. PMID: 36367377 Free PMC article.
268 results